-
Something wrong with this record ?
Neonatal Screening in Europe Revisited: An ISNS Perspective on the Current State and Developments Since 2010
JG. Loeber, D. Platis, RH. Zetterström, S. Almashanu, F. Boemer, JR. Bonham, P. Borde, I. Brincat, D. Cheillan, E. Dekkers, D. Dimitrov, R. Fingerhut, L. Franzson, U. Groselj, D. Hougaard, M. Knapkova, M. Kocova, V. Kotori, V. Kozich, A....
Language English Country Switzerland
Document type Journal Article
NLK
Directory of Open Access Journals
from 2015
PubMed Central
from 2018
ProQuest Central
from 2020-07-01
Open Access Digital Library
from 2015-01-01
Health & Medicine (ProQuest)
from 2020-07-01
ROAD: Directory of Open Access Scholarly Resources
from 2015
PubMed
33808002
DOI
10.3390/ijns7010015
Knihovny.cz E-resources
- Publication type
- Journal Article MeSH
Neonatal screening (NBS) was initiated in Europe during the 1960s with the screening for phenylketonuria. The panel of screened disorders ("conditions") then gradually expanded, with a boost in the late 1990s with the introduction of tandem mass spectrometry (MS/MS), making it possible to screen for 40-50 conditions using a single blood spot. The most recent additions to screening programmes (screening for cystic fibrosis, severe combined immunodeficiency and spinal muscular atrophy) were assisted by or realised through the introduction of molecular technologies. For this survey, we collected data from 51 European countries. We report the developments between 2010 and 2020 and highlight the achievements reached with the progress made in this period. We also identify areas where further progress can be made, mainly by exchanging knowledge and learning from experiences in neighbouring countries. Between 2010 and 2020, most NBS programmes in geographical Europe matured considerably, both in terms of methodology (modernised) and with regard to the panel of conditions screened (expanded). These developments indicate that more collaboration in Europe through European organisations is gaining momentum. We can only accomplish the timely detection of newborn infants potentially suffering from one of the many rare diseases and take appropriate action by working together.
Arbes Health Care Centre Yerevan 0014 Armenia
Center for Preventive Paediatrics 3022 Limassol Cyprus
Centre for Medical Genetics 08661 Vilnius Lithuania
Child and Adolescent Health Department 06430 Ankara Turkey
Children's Clinic 1083 Budapest Hungary
Children's University Hospital 1004 Riga Latvia
CHU Domaine du Sart Tilman 4000 Liège Belgium
Clinical and Diagnostic Center Pharmbiotest LLC 93000 Rubizhne Ukraine
Department Genetics and Molecular Medicine Landspitali Reykjavik 108 Iceland
Department of Newborn Screening Institute of Child Health 11527 Athens Greece
Department of Pediatrics and Adolescent Medicine 1090 Vienna Austria
Department of Pediatrics University Clinical Centre Tuzla 75000 Bosnia and Herzegovina
Groupement Hospitalier Est 69500 Bron France
Institute for Sick Children 81000 Podgorica Montenegro
Institute of Mother and Child 01 211 Warsaw Poland
International Society for Neonatal Screening Office 3721CK Bilthoven The Netherlands
Laboratoire National de Santé 3555 Dudelange Luxembourg
Málaga Regional University Hospital Institute of Biomedical Research IBIMA 29011 Málaga Spain
Mater Dei Hospital Tal Qroqq Msida MSD2090 Msida Malta
Medical Faculty 1000 Skopje North Macedonia
Medical Faculty University of Tartu 50411 Tart Estonia
Meyer Hospital 50139 Florence Italy
Mother and Child Health Care Institute of Serbia Belgrade 11070 Serbia
National Centre Health and Reproductive and Medical Genetics 2062 Chisinau Moldova
National Genetic Laboratory Hospital Maichin Dom 1431 Sofia Bulgaria
National Institute for Mother and Child Health 050474 Bucharest Romania
National Institute of Health 4000 055 Porto Portugal
Neonatal Screening Center 115580 Moscow Russia
Neonatal Screening Laboratory Children's Hospital CH 8032 Zürich Switzerland
NeugoGenetic and Metabolic Center Tbilisi 0194 Georgia
Newborn Blood Spot Screening Laboratory Dublin 1 Ireland
Newborn Screening Centre Banska Bystrica 97401 Slovakia
Newborn Screening Centre Turku University Hospital 20521 Turku Finland
Newborn Screening Laboratories Tel HaShomer 52621 Ramat Gan Israel
Norwegian National Unit for Newborn Screening 0424 Oslo Norway
Republican Center Mother and Child Screening Tashkent 100164 Uzbekistan
Republican Scientific Centre for Gynaecology and Perinatology Almaty 050020 Kazakhstan
Sheffield Children's NHS Foundation Trust Sheffield S10 2TH UK
Staten Serum Institute 2300 Copenhagen Denmark
University Children's Hospital 1000 Ljubljana Slovenia
University Clinic 04103 Leipzig Germany
University Clinical Centre Pristina 10000 Kosovo
University Hospital Medical Centre Zagreb 10000 Zagreb Croatia
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21018219
- 003
- CZ-PrNML
- 005
- 20210729104153.0
- 007
- ta
- 008
- 210726s2021 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/ijns7010015 $2 doi
- 035 __
- $a (PubMed)33808002
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Loeber, J Gerard $u International Society for Neonatal Screening (ISNS) Office, 3721CK Bilthoven, The Netherlands
- 245 10
- $a Neonatal Screening in Europe Revisited: An ISNS Perspective on the Current State and Developments Since 2010 / $c JG. Loeber, D. Platis, RH. Zetterström, S. Almashanu, F. Boemer, JR. Bonham, P. Borde, I. Brincat, D. Cheillan, E. Dekkers, D. Dimitrov, R. Fingerhut, L. Franzson, U. Groselj, D. Hougaard, M. Knapkova, M. Kocova, V. Kotori, V. Kozich, A. Kremezna, R. Kurkijärvi, G. La Marca, R. Mikelsaar, T. Milenkovic, V. Mitkin, F. Moldovanu, U. Ceglarek, L. O'Grady, M. Oltarzewski, RD. Pettersen, D. Ramadza, D. Salimbayeva, M. Samardzic, M. Shamsiddinova, J. Songailiené, I. Szatmari, N. Tabatadze, B. Tezel, A. Toromanovic, I. Tovmasyan, N. Usurelu, P. Vevere, L. Vilarinho, M. Vogazianos, R. Yahyaoui, M. Zeyda, PCJI. Schielen
- 520 9_
- $a Neonatal screening (NBS) was initiated in Europe during the 1960s with the screening for phenylketonuria. The panel of screened disorders ("conditions") then gradually expanded, with a boost in the late 1990s with the introduction of tandem mass spectrometry (MS/MS), making it possible to screen for 40-50 conditions using a single blood spot. The most recent additions to screening programmes (screening for cystic fibrosis, severe combined immunodeficiency and spinal muscular atrophy) were assisted by or realised through the introduction of molecular technologies. For this survey, we collected data from 51 European countries. We report the developments between 2010 and 2020 and highlight the achievements reached with the progress made in this period. We also identify areas where further progress can be made, mainly by exchanging knowledge and learning from experiences in neighbouring countries. Between 2010 and 2020, most NBS programmes in geographical Europe matured considerably, both in terms of methodology (modernised) and with regard to the panel of conditions screened (expanded). These developments indicate that more collaboration in Europe through European organisations is gaining momentum. We can only accomplish the timely detection of newborn infants potentially suffering from one of the many rare diseases and take appropriate action by working together.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Platis, Dimitris $u Department of Newborn Screening, Institute of Child Health, 11527 Athens, Greece
- 700 1_
- $a Zetterström, Rolf H $u Centre for Inherited Metabolic Diseases, Karolinska University Hospital and Department of Molecular Medicine and Surgery, Karolinska Institute, SE-17 76 Stockholm, Sweden
- 700 1_
- $a Almashanu, Shlomo $u Newborn Screening Laboratories, Tel-HaShomer, 52621 Ramat Gan, Israel
- 700 1_
- $a Boemer, François $u CHU-Domaine du Sart Tilman, 4000 Liège, Belgium
- 700 1_
- $a Bonham, James R $u Sheffield Children's NHS Foundation Trust, Sheffield S10 2TH, UK
- 700 1_
- $a Borde, Patricia $u Laboratoire National de Santé, 3555 Dudelange, Luxembourg
- 700 1_
- $a Brincat, Ian $u Mater Dei Hospital, Tal-Qroqq Msida, MSD2090 Msida, Malta
- 700 1_
- $a Cheillan, David $u Groupement Hospitalier Est, 69500 Bron, France
- 700 1_
- $a Dekkers, Eugenie $u Centre for Population Research, National Institue for Public Health and the Environment (RIVM), 3720BA Bilthoven, The Netherlands
- 700 1_
- $a Dimitrov, Dobry $u National Genetic Laboratory, Hospital Maichin Dom, 1431 Sofia, Bulgaria
- 700 1_
- $a Fingerhut, Ralph $u Neonatal Screening Laboratory, Children's Hospital, CH-8032 Zürich, Switzerland
- 700 1_
- $a Franzson, Leifur $u Department Genetics & Molecular Medicine, Landspitali, Reykjavik 108, Iceland
- 700 1_
- $a Groselj, Urh $u University Children's Hospital, 1000 Ljubljana, Slovenia
- 700 1_
- $a Hougaard, David $u Staten Serum Institute, 2300 Copenhagen, Denmark
- 700 1_
- $a Knapkova, Maria $u Newborn Screening Centre, Banska Bystrica 97401, Slovakia
- 700 1_
- $a Kocova, Mirjana $u Medical Faculty, 1000 Skopje, North Macedonia
- 700 1_
- $a Kotori, Vjosa $u University Clinical Centre, Pristina 10000, Kosovo
- 700 1_
- $a Kozich, Viktor $u Department of Pediatrics and Inherited Metabolic Disorders, Charles University-First Faculty of Medicine and General University Hospital, Prague 12808, Czech Republic
- 700 1_
- $a Kremezna, Anastasiia $u Clinical and Diagnostic Center "Pharmbiotest", LLC 93000 Rubizhne, Ukraine
- 700 1_
- $a Kurkijärvi, Riikka $u Newborn Screening Centre, Turku University Hospital, 20521 Turku, Finland
- 700 1_
- $a La Marca, Giancarlo $u Meyer Hospital, 50139 Florence, Italy
- 700 1_
- $a Mikelsaar, Ruth $u Medical Faculty, University of Tartu, 50411 Tart, Estonia
- 700 1_
- $a Milenkovic, Tatjana $u Mother and Child Health Care Institute of Serbia, Belgrade 11070, Serbia
- 700 1_
- $a Mitkin, Vyacheslav $u Neonatal Screening Center, 115580 Moscow, Russia
- 700 1_
- $a Moldovanu, Florentina $u National Institute for Mother and Child Health, 050474 Bucharest, Romania
- 700 1_
- $a Ceglarek, Uta $u University Clinic, 04103 Leipzig, Germany
- 700 1_
- $a O'Grady, Loretta $u Newborn Blood Spot Screening Laboratory, Dublin 1, Ireland
- 700 1_
- $a Oltarzewski, Mariusz $u Institute of Mother and Child, 01-211 Warsaw, Poland
- 700 1_
- $a Pettersen, Rolf D $u Norwegian National Unit for Newborn Screening, 0424 Oslo, Norway
- 700 1_
- $a Ramadza, Danijela $u University Hospital Medical Centre Zagreb, 10000 Zagreb, Croatia
- 700 1_
- $a Salimbayeva, Damilya $u Republican Scientific Centre for Gynaecology and Perinatology, Almaty 050020, Kazakhstan
- 700 1_
- $a Samardzic, Mira $u Institute for Sick Children, 81000 Podgorica, Montenegro
- 700 1_
- $a Shamsiddinova, Markhabo $u Republican Center Mother and Child Screening, Tashkent 100164, Uzbekistan
- 700 1_
- $a Songailiené, Jurgita $u Centre for Medical Genetics, 08661 Vilnius, Lithuania
- 700 1_
- $a Szatmari, Ildiko $u Children's Clinic, 1083 Budapest, Hungary
- 700 1_
- $a Tabatadze, Nazi $u NeugoGenetic and Metabolic Center, Tbilisi 0194, Georgia
- 700 1_
- $a Tezel, Basak $u Child and Adolescent Health Department, 06430 Ankara, Turkey
- 700 1_
- $a Toromanovic, Alma $u Department of Pediatrics, University Clinical Centre, Tuzla 75000, Bosnia and Herzegovina
- 700 1_
- $a Tovmasyan, Irina $u Arbes Health Care Centre, Yerevan 0014, Armenia
- 700 1_
- $a Usurelu, Natalia $u National Centre Health and Reproductive & Medical Genetics, 2062 Chisinau, Moldova
- 700 1_
- $a Vevere, Parsla $u Children's University Hospital, 1004 Riga, Latvia
- 700 1_
- $a Vilarinho, Laura $u National Institute of Health, 4000-055 Porto, Portugal
- 700 1_
- $a Vogazianos, Marios $u Center for Preventive Paediatrics, 3022 Limassol, Cyprus
- 700 1_
- $a Yahyaoui, Raquel $u Málaga Regional University Hospital. Institute of Biomedical Research IBIMA, 29011 Málaga, Spain
- 700 1_
- $a Zeyda, Maximilian $u Department of Pediatrics and Adolescent Medicine, 1090 Vienna, Austria
- 700 1_
- $a Schielen, Peter C J I $u International Society for Neonatal Screening (ISNS) Office, 3721CK Bilthoven, The Netherlands
- 773 0_
- $w MED00205983 $t International journal of neonatal screening $x 2409-515X $g Roč. 7, č. 1 (2021)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33808002 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20210726 $b ABA008
- 991 __
- $a 20210729104152 $b ABA008
- 999 __
- $a ind $b bmc $g 1676579 $s 1138663
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 7 $c 1 $e 20210305 $i 2409-515X $m International journal of neonatal screening $n Int. j. neonatal screen. $x MED00205983
- LZP __
- $a Pubmed-20210726